In a nutshell, TA-specific CD8+ T cells or T cells with a chimeric antigen receptor (CAR) directed to a surface-expressed TA are hampered in their efforts to combat cancers by rapid loss of functions once they enter the tumor microenvironment (TME). This evidence concerns the gene CD8A and neoplasm.